TLR9 is essential for the propagating potential of prostate cancer cells via activation of NF-κB and STAT3, which induces the expression of key stem cell-related genes, including NKX3.1, KLF-4, BMI-1, and COL1A1 by directly interacting with their promoters 79. Here, STAT3 is linked to prostate carcinoma.